First international TNBC conference meeting report

Rida, Padmashree; Ogden, Angela; Ellis, Ian O.; Varga, Zsuzsanna; Wolff, Antonio C.; Traina, Tiffany A.; Hatzis, Christos; Palmer, Julie R.; Ambrosone, Christine B.; Lehmann, Brian D.; Nanda, Rita; Montgomery Rice, Valerie; Brawley, Otis W.; Torres, Mylin A.; Rakha, Emad; Aneja, Ritu

doi:10.1007/s10549-018-4692-3

Authors

Padmashree Rida

Angela Ogden

Professor IAN ELLIS IAN.ELLIS@NOTTINGHAM.AC.UK
Professor of Cancer Pathology

Zsuzsanna Varga

Antonio C. Wolff

Tiffany A. Traina

Christos Hatzis

Julie R. Palmer

Christine B. Ambrosone

Brian D. Lehmann

Rita Nanda

Valerie Montgomery Rice

Otis W. Brawley

Mylin A. Torres

EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology

Ritu Aneja

Abstract

Recently, Georgia State University’s Centennial Hall was the premier location for the 2017 International Conference on Triple Negative Breast Cancer (TNBC): Illuminating Actionable Biology, which was held from Sept. 18 to 20, 2017, in Atlanta, USA. The conference featured a stellar line-up of domestic and international speakers and diverse participants including TNBC survivors, luminaries in breast cancer research, medical students and fellows, clinicians, translational researchers, epidemiologists, biostatisticians, bioinformaticians, and representatives from the industry. This report distills the burning questions that spiked the event and summarizes key themes, findings, unique opportunities and future directions that emerged from this confluence of thought leaders.

Citation

Rida, P., Ogden, A., Ellis, I. O., Varga, Z., Wolff, A. C., Traina, T. A., …Aneja, R. (2018). First international TNBC conference meeting report. Breast Cancer Research and Treatment, 169(3), 407-412. https://doi.org/10.1007/s10549-018-4692-3

Journal Article Type	Article
Acceptance Date	Jan 23, 2018
Online Publication Date	Feb 8, 2018
Publication Date	2018-06
Deposit Date	Oct 24, 2018
Journal	Breast Cancer Research and Treatment
Print ISSN	0167-6806
Electronic ISSN	1573-7217
Publisher	Springer Verlag
Peer Reviewed	Peer Reviewed
Volume	169
Issue	3
Pages	407-412
DOI	https://doi.org/10.1007/s10549-018-4692-3
Keywords	Triple negative breast cancer; Racial disparities; Targeted drugs; Immunotherapy; Molecular subtypes
Public URL	https://nottingham-repository.worktribe.com/output/1186469
Publisher URL	https://link.springer.com/article/10.1007%2Fs10549-018-4692-3